Perinatal listeriosis: a population-based multicenter study in Barcelona, Spain (1990-1996). NLM AIDSLINE Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Perinatal listeriosis: a population-based multicenter study in Barcelona, Spain (1990-1996).

Am J Perinatol. 1998 Aug;15(8):461-7. Unique Identifier : AIDSLINE MED/99002693
Nolla-Salas J; Bosch J; Gasser I; Vinas L; de Simon M; Almela M; Latorre C; Coll P; Ferrer MD; Intensive Care Unit, Hospital del Mar, Autonomous University of; Barcelona, Spain.


Abstract: The aim off this study was to describe the incidence, epidemiology, clinical presentation, and outcome of perinatal listeriosis for a 7-year period (1990-1996) based on data of an active population-based surveillance project implemented in the city of Barcelona, Spain. There were 30 cases (20.8%) associated with pregnancy (15 pregnant women, 13 neonates, and 2 fetal deaths). The incidence of perinatal listeriosis varied from 4.1 to 0 per 10,000 live births. The proportion of perinatal cases in relation to the total number of cases of listeriosis varied between 0 and 42%. Early-onset neonatal sepsis accounted for 12 of 13 live births. The mean age of infected pregnant women with listeriosis was 30.1+/-2.0 years. Chorioamnionitis was the predominant clinical form (86.7%). Only two mothers had primary bacteremia by L. monocytogenes in the second trimester of pregnancy. Both infants were born healthy, without signs of infection. One of these mothers was infected with the human immunodeficiency virus (HIV). Since January 1994, 12 strains were available for serotyping and phagotyping; 9 belonged to serovar 4b, 2 to serovar 1/2b, and 1 to serovar 1/2a. No outbreaks of L. monocytogenes infection occurred during the study period.The overall neonatal mortality rate was 7.7% among infected live births. All pregnant women were treated with ampicillin and none died. Early antenatal treatment with ampicillin improves neonatal outcome and can result in the birth of healthy babies.
Keywords: JOURNAL ARTICLE MULTICENTER STUDY Adult Case Report Chorioamnionitis/DIAGNOSIS/EPIDEMIOLOGY/MICROBIOLOGY Diagnosis, Differential Female Human Incidence Infant, Newborn Listeria monocytogenes/ISOLATION & PURIF Listeria Infections/*DIAGNOSIS/*EPIDEMIOLOGY Male *Population Surveillance Pregnancy *Pregnancy Complications, Infectious/DIAGNOSIS/EPIDEMIOLOGY/ MICROBIOLOGY Pregnancy Outcome Retrospective Studies Serotyping Spain/EPIDEMIOLOGYKWDjournalarticlemulticenterstudyadultcasereportchorioamnionitis/diagnosis/epidemiology/microbiologydiagnosis,differentialfemalehumanincidenceinfant,newbornlisteriamonocytogenes/isolation&puriflisteriainfections/KWDdiagnosis/KWDepidemiologymaleKWDpopulationsurveillancepregnancyKWDpregnancycomplications,infectious/diagnosis/epidemiology/microbiologypregnancyoutcomeretrospectivestudiesserotypingspain/epidemiology
990330
A9931127

Copyright © 1999 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .